Print ISSN: 3071-0871 · Online ISSN: 3071-088X
Latest Issue
Academic Partner
Neuro-Drug Discovery
Open AccessPrint ISSN: 3071-0871
Online ISSN: 3071-088X
Our journal publishes basic and clinical research in neuroscience, pharmacology, and clinical medicine. From bench to bedside, we publish rigorous interdisciplinary research advancing the discovery, development, and regulation of neuro-targeted therapeutics and devices.
Why publish in Neuro-Drug Discovery?
-
Reach audiences in interdisciplinary fields including neuroscientists, physicians, pharmacologists and pharmaceutical scientists
-
With a simplified publication process, you'll have more time to focus on what matters - your research
-
Benefit from the support of an Editorial Board who are experts in their field
Honorary Editor-in-Chief
Patrick Y. Wen
Harvard Medical School, Boston, MA, United States. Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, United States
Editor-in-Chief
Wenbin Li
Department of Neuro-Oncology, Cancer Center, Beijing . Tiantan Hospital, Capital Medical University, Beijing, China
Co-Editor-in-Chief
Aya El-Helali
Department of Clinical Oncology, The University of Hong Kong, Hong Kong, China
Co-Editor-in-Chief
Giuseppe Lombardi
Veneto Institute of Oncology, Medical Oncology 1 Unit, Padua, Italy
Executive Editor-in-Chief
Yufeng Shi
School of Medicine, Tongji University, Shanghai, China
Assistant Editor-in-Chief
Feng Chen
Department of Neuro-oncology, Cancer Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
Associate Editors
Huisheng Chen
Department of Neurology, General Hospital of Northern Theater Command, Shenyang, China
Associate Editors
Zhen Wu
Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China